Complement Inhibition for the Treatment of Myasthenia Gravis
Renato Mantegazza, Fiammetta Vanoli, Rita Frangiamore, Paola Cavalcante Neurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, ItalyCorrespondence: Renato MantegazzaNeurology IV - Neuroimmunology and Neuromuscular Diseases Unit, Fond...
Main Authors: | Mantegazza R, Vanoli F, Frangiamore R, Cavalcante P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/complement-inhibition-for-the-treatment-of-myasthenia-gravis-peer-reviewed-article-ITT |
Similar Items
-
Complement Inhibitor Therapy for Myasthenia Gravis
by: Khaled Albazli, et al.
Published: (2020-06-01) -
Novel Treatments in Myasthenia Gravis
by: Deepak Menon, et al.
Published: (2020-06-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01) -
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
by: Renato Mantegazza, et al.
Published: (2020-09-01) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016-03-01)